RPbio Inc. Logo

RPbio Inc.

A global CDMO specializing in soft capsules, pharmaceuticals, and health functional foods.

314140 | KO

Overview

Corporate Details

ISIN(s):
KR7314140005
LEI:
Country:
South Korea
Address:
서울특별시 강남구 삼성로 634, 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

RPbio Inc. is a bio-health company specializing in the contract development and manufacturing (CDMO) of soft capsules, pharmaceuticals, and health functional foods. Established in 1983 as a joint venture between Daewoong Pharmaceutical and R.P. Scherer Corporation, the company leverages extensive expertise in advanced softgel technologies. RPbio provides comprehensive OEM/ODM services to domestic and international clients in the pharmaceutical and health supplement industries, positioning itself as a leading global producer of soft capsules.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 703.4 KB
2025-07-22 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-06-30 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 623.2 KB
2025-03-31 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 21.7 KB
2025-03-21 00:00
Annual Report
사업보고서 (2024.12)
Korean 977.6 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 18.3 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.2 KB
2025-03-14 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 69.6 KB
2025-02-14 00:00
Earnings Release
매출액또는손익구조30%(대규모법인은15%)이상변동
Korean 10.7 KB
2024-12-16 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.1 KB
2024-11-14 00:00
Quarterly Report
분기보고서 (2024.09)
Korean 619.5 KB
2024-08-14 00:00
Interim Report
반기보고서 (2024.06)
Korean 775.3 KB
2024-05-14 00:00
Quarterly Report
분기보고서 (2024.03)
Korean 793.3 KB
2024-03-29 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 24.5 KB

Automate Your Workflow. Get a real-time feed of all RPbio Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for RPbio Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for RPbio Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea
196170
ALTERITY THERAPEUTICS LTD Logo
Developing therapies for Parkinsonian disorders and MSA by inhibiting protein aggregation.
United States of America
ATHE
Alto Neuroscience, Inc. Logo
Developing precision medicines for depression and schizophrenia using a brain biomarker platform.
United States of America
ANRO
ALUMIS INC. Logo
Develops targeted oral therapies for immune-mediated diseases using precision immunology.
United States of America
ALMS
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg
ALVO
ALX ONCOLOGY HOLDINGS INC Logo
Clinical-stage firm developing CD47 inhibitors for hematologic and solid tumors.
United States of America
ALXO
Alzamend Neuro, Inc. Logo
Developing lithium & vaccine therapies for neurodegenerative & psychiatric disorders.
United States of America
ALZN
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden
ALZ
AMARIN CORP PLC\UK Logo
Develops prescription therapies like Vascepa® to reduce cardiovascular risk for patients.
United States of America
AMRN
AMGEN INC Logo
Biotech pioneer developing innovative human therapeutics for the world's toughest diseases.
United States of America
AMGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.